Science Daily -
18 Mar 2018 20:48
New scientific evidence has strengthened the case for reserving testosterone therapy for well-documented cases of hypogonadism, a condition where the body does not produce enough testosterone, experts concluded in an updated Clinical Practice Guideline.
Share this Article